S&P 500

5.370,39

0,18%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Infinity Pharmaceuticals Inc (INFI)
Infinity Pharmaceuticals Inc (INFI) Notícias

INFI

Infinity Pharmaceuticals (INFI)

Infinity Pharmaceuticals Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:INFI

1 2 3 4 5 6 7 8 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
13/09/2023	09:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INFI	Infinity Pharmaceuticals Inc
12/09/2023	19:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INFI	Infinity Pharmaceuticals Inc
10/08/2023	17:32	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:INFI	Infinity Pharmaceuticals Inc
25/07/2023	17:05	Business Wire	Infinity Pharmaceuticals Announces Value Preservation and Maximization Plan	NASDAQ:INFI	Infinity Pharmaceuticals Inc
24/07/2023	09:30	Business Wire	Infinity Pharmaceuticals Announces Termination of Merger Agreement with MEI Pharma	NASDAQ:INFI	Infinity Pharmaceuticals Inc
14/07/2023	14:00	Business Wire	Infinity Pharmaceuticals Announces Stockholder Approval of Merger with MEI Pharma	NASDAQ:INFI	Infinity Pharmaceuticals Inc
10/07/2023	09:30	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:INFI	Infinity Pharmaceuticals Inc
10/07/2023	09:30	Business Wire	Infinity Pharmaceuticals Provides Additional Information on MARIO-8 Study Evaluating Eganelisib in Combination with the PD-1 Targeted Checkpoint Inhibitor Pembrolizumab (KEYTRUDA®) in Patients with Squamous Cell Cancer of the Head and Neck (SCCHN)	NASDAQ:INFI	Infinity Pharmaceuticals Inc
05/07/2023	09:30	Business Wire	ISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.	NASDAQ:INFI	Infinity Pharmaceuticals Inc
03/07/2023	17:57	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:INFI	Infinity Pharmaceuticals Inc
27/06/2023	09:31	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:INFI	Infinity Pharmaceuticals Inc
20/06/2023	09:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INFI	Infinity Pharmaceuticals Inc
15/06/2023	13:08	Business Wire	MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates	NASDAQ:INFI	Infinity Pharmaceuticals Inc
13/04/2023	17:05	Business Wire	Infinity Pharmaceuticals Announces Two Upcoming Presentations on PI3K-γ and Eganelisib by Dr. Judith Varner at the 2023 Annual Meeting of the American Association of Cancer Research	NASDAQ:INFI	Infinity Pharmaceuticals Inc
28/03/2023	17:05	Business Wire	Infinity Pharmaceuticals Reports Full Year 2022 Financial Results	NASDAQ:INFI	Infinity Pharmaceuticals Inc
28/03/2023	16:58	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:INFI	Infinity Pharmaceuticals Inc
23/02/2023	19:32	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:INFI	Infinity Pharmaceuticals Inc
23/02/2023	15:19	PR Newswire (US)	ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Infinity Pharmaceuticals, Inc.	NASDAQ:INFI	Infinity Pharmaceuticals Inc
23/02/2023	09:00	Business Wire	MEI Pharma and Infinity Pharmaceuticals Announce Definitive Merger Agreement to Advance Three Promising Clinical Oncology Candidates	NASDAQ:INFI	Infinity Pharmaceuticals Inc
09/02/2023	13:36	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:INFI	Infinity Pharmaceuticals Inc
22/11/2022	10:35	Business Wire	Infinity Pharmaceuticals to Participate in Piper Sandler 34th Annual Healthcare Conference	NASDAQ:INFI	Infinity Pharmaceuticals Inc
14/11/2022	14:40	TipRanks	Analysts Offer Insights on Healthcare Companies: Gamida Cell (GMDA) and Infinity Pharma (INFI)	NASDAQ:INFI	Infinity Pharmaceuticals Inc
14/11/2022	09:07	Business Wire	Infinity Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update	NASDAQ:INFI	Infinity Pharmaceuticals Inc
14/11/2022	09:05	Business Wire	Infinity Pharmaceuticals Provides MARIO-3 Update in Patients with Front Line Metastatic Triple Negative Breast Cancer Suggesting Potential Long-Term Patient Benefit of Eganelisib	NASDAQ:INFI	Infinity Pharmaceuticals Inc
07/11/2022	10:25	Business Wire	Infinity Pharmaceuticals Announces the Date of Its Third Quarter 2022 Financial Results Conference Call and Webcast	NASDAQ:INFI	Infinity Pharmaceuticals Inc
31/08/2022	08:00	Business Wire	Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences	NASDAQ:INFI	Infinity Pharmaceuticals Inc
12/08/2022	16:05	TipRanks	JonesTrading Reaffirms Their Hold Rating on Infinity Pharma (INFI)	NASDAQ:INFI	Infinity Pharmaceuticals Inc
09/08/2022	17:05	Business Wire	Infinity Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update	NASDAQ:INFI	Infinity Pharmaceuticals Inc
09/08/2022	16:52	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:INFI	Infinity Pharmaceuticals Inc
04/08/2022	19:28	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INFI	Infinity Pharmaceuticals Inc